RACIOPPI, LUIGI
RACIOPPI, LUIGI
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Modulation of CD45 tyrosine phosphatase activity by antigen.
2001 LAGO PAZ, F; Galgani, M; D'Oro, U; Matarese, G; Masci, Am; Zappacosta, S; Racioppi, Luigi
The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling
1996 Racioppi, Luigi; Matarese, M; D'Oro, U; DE PASCALE, Mt; Masci, Am; Fontana, S.; Zappacosta, S.
The molecular basis of class II MHC allelic control of T cell responses.
1991 Racioppi, Luigi; Ronchese, F; Schwartz, Rh; Germain, Rn
The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition.
1993 Boehncke, Wh; Takeshita, T; Pendleton, Cd; Houghten, Ra; SADEGH NASSERI, S; Racioppi, Luigi; Berzofsky, Ja; Germain, Rn
HLA class II molecules transduce accessory signals affecting the CD3, but not IL-2 activation pathaway in T blast.
1993 Di Rosa, F.; D’Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Ferrone, S.; Fontana, S.; Zappacosta, S.
Major Histocompatibility Complex Class II molecules transduce activation signals in Human T blasts.
1992 D’Oro, U; Di Rosa, F.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Chianca, R; Ferrone, S.; Fontana, S.; Zappacosta, S.
The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice.
2012 Barberi, Tj; Dunkle, A; He, Yw; Racioppi, Luigi; Means, Ar
Phase II monitored clinical trial for evaluation of treatment of patients with Thymic Epithelial Tumours (TET) or Histiocitosi X (LCH) with Imatinib Mesylate.
2008 Racioppi, Luigi
Inhibition by anti-HLA class II monoclonal antibodies of monoclonal antibody OKT3-induced T cell proliferation. Studies at the mRNA level
1990 Racioppi, Luigi; Moscarella, A; Ruggiero, Giuseppina; Manzo, C; Ferrone, S; Fontana, S; Zappacosta,
HLA Class II molecules trabsduce accessory signals affecting the CD3 but not the intreleukin-2 activation pathway in T blasts
1993 DI ROSA, F.; D'Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, A. M.; Ferrone, S.; Fontana, S.; Zappacosta, S.
Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes.
2003 Frasca, L; Scotta, C; DEL PORTO, P; Nicosia, A; Pasquazzi, C; Versace, I; Masci, Am; Racioppi, Luigi; Piccolella, E.
IMMUNOLOGICAL FINDINGS IN THYMOMA AND THYMOMA-RELATED SYNDROMES
1999 Masci, Am; Palmieri, G; Perno, F; Montella, L; Racioppi, Luigi
TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.
2007 Damiano, V; Caputo, R; Garofalo, S; Bianco, Roberto; Rosa, R; Merola, G; Gelardi, T; Racioppi, Luigi; Fontanini, G; DE PLACIDO, Sabino; Kandimalla, Er; Agrawal, S; Ciardiello, F; Tortora, Giampaolo
Human equivalent of the mouse nude/SCID phenotype: Long-term evolvation of immunological reconstitution after bone marrow transplantation.
2001 Pignata, Claudio; Gaetaniello, L.; Masci, A. M.; Frank, J.; Christiano, A.; Matrecano, E.; Racioppi, Luigi
NK and LAK susceptibility varies inversely with target cell MHC class I antigen expression in a rat epithelial tumour system.
1991 Carbone, E; Racioppi, Luigi; LA CAVA, A; Portella, Giuseppe; Velotti, F; Zappacosta, S; Fontana, S.
Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy.
2002 Matarese, G; CASTELLI GATTINARA, G; Cancrini, C; Bernardi, S; Romiti, Ml; Savarese, C; DI GIACOMO, A; Rossi, P; Racioppi, Luigi
Defective dendritic cell maturation in a child with nucleotide excision repair deficiency and CD4 lymphopenia
2001 Racioppi, Luigi; Cancrini, C; Romiti, Ml; Angelini, F; DI CESARE, S; Bertini, E; Livadiotti, S; Gambarara, Mg; Matarese, Giuseppe; LAGO PAZ, F; Stefanini, M; Rossi, P.
Hydroxytyrosol, a natural molecule occurring in olive oil, induces cytochrome c-dependent apoptosis
2000 Ragione, Fd; Cucciolla, V; Borriello, A; Pietra, Vd; Pontoni, G; Racioppi, Luigi; Manna, C; Galletti, P; Zappia, V.
The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients
2001 Montanaro, D.; Sanna, V.; Matarese, G.; Larby, B. B.; Racioppi, Luigi; Carrieri, P. B.; Bruno, R.; Davey, N. J.; Zappacosta, Serafino; Fontana, S.
T cell activation deficiency associated with an aberrant pattern of protein tyrosine phosphorylation after CD3 perturbation in Down's syndrome.
1998 Scotese, I; Gaetaniello, L; Matarese, G; Lecora, M; Racioppi, Luigi; Pignata, C.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Modulation of CD45 tyrosine phosphatase activity by antigen. | 1.1 Articolo in rivista | 2001 | LAGO PAZ, F; Galgani, M; D'Oro, U; Matarese, G; Masci, Am; Zappacosta, S; Racioppi, Luigi | |
| The role of CD4-Lck in T-cell receptor antagonism: evidence for negative signaling | 1.1 Articolo in rivista | 1996 | Racioppi, Luigi; Matarese, M; D'Oro, U; DE PASCALE, Mt; Masci, Am; Fontana, S.; Zappacosta, S. | |
| The molecular basis of class II MHC allelic control of T cell responses. | 1.1 Articolo in rivista | 1991 | Racioppi, Luigi; Ronchese, F; Schwartz, Rh; Germain, Rn | |
| The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. | 1.1 Articolo in rivista | 1993 | Boehncke, Wh; Takeshita, T; Pendleton, Cd; Houghten, Ra; SADEGH NASSERI, S; Racioppi, Luigi; Berzofsky, Ja; Germain, Rn | |
| HLA class II molecules transduce accessory signals affecting the CD3, but not IL-2 activation pathaway in T blast. | 1.1 Articolo in rivista | 1993 | Di Rosa, F.; D’Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Ferrone, S.; Fontana, S.; Zappacosta, S. | |
| Major Histocompatibility Complex Class II molecules transduce activation signals in Human T blasts. | 2.1 Contributo in volume (Capitolo o Saggio) | 1992 | D’Oro, U; Di Rosa, F.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, ANGELA MARIA; Chianca, R; Ferrone, S.; Fontana, S.; Zappacosta, S. | |
| The prolyl isomerase Pin1 modulates development of CD8+ cDC in mice. | 1.1 Articolo in rivista | 2012 | Barberi, Tj; Dunkle, A; He, Yw; Racioppi, Luigi; Means, Ar | |
| Phase II monitored clinical trial for evaluation of treatment of patients with Thymic Epithelial Tumours (TET) or Histiocitosi X (LCH) with Imatinib Mesylate. | 8.03 Conv. e contr. di ricerca di Enti Pubblici/Privati | 2008 | Racioppi, Luigi | |
| Inhibition by anti-HLA class II monoclonal antibodies of monoclonal antibody OKT3-induced T cell proliferation. Studies at the mRNA level | 1.1 Articolo in rivista | 1990 | Racioppi, Luigi; Moscarella, A; Ruggiero, Giuseppina; Manzo, C; Ferrone, S; Fontana, S; Zappacosta, | |
| HLA Class II molecules trabsduce accessory signals affecting the CD3 but not the intreleukin-2 activation pathway in T blasts | 1.1 Articolo in rivista | 1993 | DI ROSA, F.; D'Oro, U.; Ruggiero, Giuseppina; Racioppi, Luigi; Acquaviva, A. M.; Ferrone, S.; Fontana, S.; Zappacosta, S. | |
| Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes. | 1.1 Articolo in rivista | 2003 | Frasca, L; Scotta, C; DEL PORTO, P; Nicosia, A; Pasquazzi, C; Versace, I; Masci, Am; Racioppi, Luigi; Piccolella, E. | |
| IMMUNOLOGICAL FINDINGS IN THYMOMA AND THYMOMA-RELATED SYNDROMES | 1.1 Articolo in rivista | 1999 | Masci, Am; Palmieri, G; Perno, F; Montella, L; Racioppi, Luigi | |
| TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts. | 1.1 Articolo in rivista | 2007 | Damiano, V; Caputo, R; Garofalo, S; Bianco, Roberto; Rosa, R; Merola, G; Gelardi, T; Racioppi, Luigi; Fontanini, G; DE PLACIDO, Sabino; Kandimalla, Er; Agrawal, S; Ciardiello, F; Tortora, Giampaolo | |
| Human equivalent of the mouse nude/SCID phenotype: Long-term evolvation of immunological reconstitution after bone marrow transplantation. | 1.1 Articolo in rivista | 2001 | Pignata, Claudio; Gaetaniello, L.; Masci, A. M.; Frank, J.; Christiano, A.; Matrecano, E.; Racioppi, Luigi | |
| NK and LAK susceptibility varies inversely with target cell MHC class I antigen expression in a rat epithelial tumour system. | 1.1 Articolo in rivista | 1991 | Carbone, E; Racioppi, Luigi; LA CAVA, A; Portella, Giuseppe; Velotti, F; Zappacosta, S; Fontana, S. | |
| Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy. | 1.1 Articolo in rivista | 2002 | Matarese, G; CASTELLI GATTINARA, G; Cancrini, C; Bernardi, S; Romiti, Ml; Savarese, C; DI GIACOMO, A; Rossi, P; Racioppi, Luigi | |
| Defective dendritic cell maturation in a child with nucleotide excision repair deficiency and CD4 lymphopenia | 1.1 Articolo in rivista | 2001 | Racioppi, Luigi; Cancrini, C; Romiti, Ml; Angelini, F; DI CESARE, S; Bertini, E; Livadiotti, S; Gambarara, Mg; Matarese, Giuseppe; LAGO PAZ, F; Stefanini, M; Rossi, P. | |
| Hydroxytyrosol, a natural molecule occurring in olive oil, induces cytochrome c-dependent apoptosis | 1.1 Articolo in rivista | 2000 | Ragione, Fd; Cucciolla, V; Borriello, A; Pietra, Vd; Pontoni, G; Racioppi, Luigi; Manna, C; Galletti, P; Zappia, V. | |
| The fine specificity of human T cell lines towards myelin basic protein peptides in southern Italian multiple sclerosis patients | 1.1 Articolo in rivista | 2001 | Montanaro, D.; Sanna, V.; Matarese, G.; Larby, B. B.; Racioppi, Luigi; Carrieri, P. B.; Bruno, R.; Davey, N. J.; Zappacosta, Serafino; Fontana, S. | |
| T cell activation deficiency associated with an aberrant pattern of protein tyrosine phosphorylation after CD3 perturbation in Down's syndrome. | 1.1 Articolo in rivista | 1998 | Scotese, I; Gaetaniello, L; Matarese, G; Lecora, M; Racioppi, Luigi; Pignata, C. |